GlassScriptPhysician profile
Salvacion D Ramirez
NPI 1013901321
$1,785.50
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $638 · 2020: $515 · 2021: $632.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $320.75 | 2019-2021 | |
| Lilly USA, LLC | $286.42 | 2019-2021 | |
| Novo Nordisk INC | $237.63 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $149.25 | 2019-2021 | |
| Amarin Pharma, INC. | $118.74 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $106.08 | 2019-2021 | |
| Medtronic Vascular, INC. | $102.65 | 2019 | |
| Merck Sharp & Dohme LLC | $82.27 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $51.23 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $46.89 | 2021 | |
| Pfizer INC. | $46.85 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $39.83 | 2021 | |
| Novartis Pharmaceuticals Corporation | $33.10 | 2019 | |
| Allergan, INC. | $30.97 | 2019-2020 | |
| Horizon Therapeutics Plc | $25.45 | 2019-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $22.40 | 2020 | |
| Esperion Therapeutics, INC. | $19.99 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.20 | 2019 | |
| Abbott Laboratories | $16.21 | 2021 | |
| Abbvie INC. | $15.30 | 2021 | |
| Sun Pharmaceutical Industries INC. | $14.29 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salvacion Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.